The latest available statistics for children's cancer in the UK are; incidence of all cancers combined 2012-2014, incidence by cancer type 2006-2008, incidence by cancer subtype 1996-2005, mortality from all cancers combined 2012-2014, mortality by cancer type 1996-2005, and survival 2006-2010.
Statistics for specific cancer types are also available for earlier time periods in Great Britain.
The ICD codes for all children's cancers incidence and survival are ICD-10 C00-C97 excluding C44 (all malignant neoplasms excluding non-melanoma skin cancer), and ICD-10 D32-D33, D35.2-D35.4, D42-D43 and D44.3-D44.5 (all benign and uncertain or unknown behaviour brain, other central nervous system [CNS] and intracranial tumours).
The ICD codes for all children's cancers mortality are ICD-10 C00-C97 (all malignant tumours), and ICD-10 D32-D33, D35.2-D35.4, D42-D43 and D44.3-D44.5 (all benign, uncertain and unknown brain, other central nervous system [CNS] and intracranial tumours).
'Childhood' or 'children' refers to those persons aged 0 to 14, inclusively.
Cancer is rare in children compared with the adult population and for this reason incidence and mortality rates are presented per million rather than per 100,000 population. The rarity of cancer in childhood also means that there is much international collaboration for children's cancer research, so World (rather than European) age-standardised rates (AS rates) are presented to allow comparisons with international publications. However, Europeans AS rates are available to download.
Survival statistics give an overall picture of survival and (unless otherwise stated) include all adults (15-99) diagnosed, at all ages, stages and co-morbidities. The survival time experienced by an individual patient may be much higher or lower, depending on specific patient and tumour characteristics.
Meta-analyses and systematic reviews are cited where available, as they provide the best overview of all available research and most take study quality into account. Individual case-control and cohort studies are reported where such aggregated data are lacking.
Time periods for the follow-up statistics are detailed within the content.
See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of the statistics are also available.